CD79A and neoplasm: To test whether CD79a expressed on myeloid cells is structurally different from that expressed on B cells, protein was extracted for western blot analysis from splenocytes of naive mice or from mice with a heavy 4T1 tumor burden such that nearly 90% of the splenocytes were immature myeloid cells.